DDrare: Database of Drug Development for Rare Diseases

57. 特発性拡張型心筋症
［臨床試験数：12，薬物数：25（DrugBank：12），標的遺伝子数：9，標的パスウェイ数：33］

Searched query = "Idiopathic dilated cardiomyopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 18F-deoxyglucose (FDG); Allopurinol; Benazepril; Carvedilol; Coenzyme Q10; Dobutamine; Doxazosin; GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF); Granocyte; Granocyte Lenograstim; Granulocyte Colony Stimulating Factor; Granulocyte colony stimulating factor (GCSF); HTEA; Honey; Infusion of autologous mononuclear bone marrow cells; Lenograstim; Metoprolol; Metoprolol succinate; Metoprolol succinate + doxazosin; Mono Nuclear Cell (MNC) transplantation; PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION); Procedure: bone marrow mononuclear cells; Umbilical cord mesenchymal stem cells; Valsartan; Water

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02256501 (ClinicalTrials.gov)	June 2013	1/10/2014	Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy	Intracoronary Transplantation of Autologous Bone Marrow Derived Mononuclear Cells (MNC) in Idiopathic Dilated Cardiomyopathy in Pediatric Patients: Clinical Trial Phase I/II	Cardiomyopathy	Biological: Mono Nuclear Cell (MNC) transplantation	Nasser Aghdami MD., PhD	NULL	Completed	1 Year	16 Years	All	30	Phase 1;Phase 2	Iran, Islamic Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02256501
(ClinicalTrials.gov)

June 2013

1/10/2014

Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy

Intracoronary Transplantation of Autologous Bone Marrow Derived Mononuclear Cells (MNC) in Idiopathic Dilated Cardiomyopathy in Pediatric Patients: Clinical Trial Phase I/II

Cardiomyopathy

Biological: Mono Nuclear Cell (MNC) transplantation

Nasser Aghdami MD., PhD

NULL

Completed

1 Year

16 Years

All

Phase 1;Phase 2

Iran, Islamic Republic of